Correia Da Cruz, L., Diederich, M., & Cerella, C. (03 July 2024). Immunophenotype profiling classifies AML patient susceptibility to immunotherapies [Poster presentation]. ISCaM, International Society of Cancer Metabolism, Bruxelles, Belgium. |
![]() ![]() | Correia Da Cruz, L. (06 February 2024). Immunophenotype profiling classifies AML patient susceptibility to immunotherapies [Poster presentation]. Televie Seminar, Bruxelles, Belgium. |